Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 EUR | 0.00% |
|
+4.72% | +112.80% |
26/04 | Labiana Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2022 | Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma. | CI |
Sales 2024 * | 6.6Cr 7.07Cr 589.9Cr | Sales 2025 * | 7.2Cr 7.71Cr 643.53Cr | Capitalization | 1.88Cr 2.01Cr 167.88Cr |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 10L 10.71L 8.94Cr | EV / Sales 2024 * | 0.81 x |
Net Debt 2024 * | 3.5Cr 3.75Cr 312.83Cr | Net Debt 2025 * | 3.5Cr 3.75Cr 312.83Cr | EV / Sales 2025 * | 0.75 x |
P/E ratio 2024 * |
133
x | P/E ratio 2025 * |
13.6
x | Employees | 433 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 29.88% |
1 week | +4.72% | ||
Current month | +18.75% | ||
1 month | +26.67% | ||
3 months | +71.61% | ||
6 months | +118.03% | ||
Current year | +112.80% |
![Extreme 2.54](/images/extremecours_fleche.png)
![Extreme 1.95](/images/extremecours_fleche.png)
![Extreme 1.18](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
![Extreme 1.05](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Miquel Pujolriu
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 2.66 | 0.00% | 4,110 |
24/24/24 | 2.66 | +4.72% | 3,909 |
21/24/21 | 2.54 | 0.00% | 1,000 |
20/24/20 | 2.54 | 0.00% | 0 |
19/24/19 | 2.54 | 0.00% | 0 |
Delayed Quote BME, June 25, 2024 at 09:05 pm IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+112.80% | 2.01Cr | |
+19.80% | 882.11Cr | |
+21.88% | 360.08Cr | |
-6.82% | 300.1Cr | |
+12.50% | 165.38Cr | |
-6.05% | 121.83Cr | |
-33.05% | 110.91Cr | |
-35.50% | 107.57Cr | |
-27.33% | 95Cr | |
+1.79% | 94Cr |
- Stock Market
- Equities
- LAB Stock